Lenoss Medical Secures Investment from Xcellerant Ventures.The deal’s total value was not made public.
Read also – Turkey-based Getir Completes Acquisition of FreshDirect
With the funding, the business hopes to further the development and commercialization of OsteoPearl, a biological option for treating osteoporotic vertebral compression fractures that doctors can prescribe.
Read also – Webster Financial Corporation Acquire Ametros Financial Corp
Lenoss, under the leadership of CEO Dom Messerli, is developing the OsteoPearl VBA System, that utilises minimally invasive, cement-free technology along with healthy bone’s inherent healing abilities to provide a wholly biologic solution for stabilising spinal fractures.
About Lenoss Medical
Lenoss Medical, In vertebral body augmentation, a surgical tool is inserted into a broken vertebral body caused by osteoporosis or trauma. A device is inserted to fill the hollow and stabilise the fractured vertebrae once the cavity has been formed. A regenerative event takes place when a biologic is utilised to fill the void; new bone grows and the afflicted vertebrae gradually mend.
Read also – CA-based Distributional Secures $11m in Seed Funding
